Winner of the 2025 National Pharmaceutical Technology Award (Medical Device Category)

[Bronze Award, Medical Device Category: Bio Preventive Medicine Corp. for "DNlite Test"]

Through a non-invasive urine test, DNlite effectively predicts the 5-year risk of renal function decline in diabetic patients, facilitating personalized care and early medical intervention.

The National Pharmaceutical Technology and Research Development Award remains steadfast in its mission of "Pioneering Pharmaceuticals, Soaring Globally." By continuously advancing technological research and development in drugs and medical devices, the Award drives the robust growth and prosperity of the biomedical industry.

Furthermore, it actively supports President Lai's "Healthy Taiwan" policy, embodying the ultimate vision: "Healthy People, a Stronger Nation, and a Taiwan Embraced by the World."

Related News Links:

2025國家藥科獎得獎名單隆重揭曉 獎勵生醫產業共創「健康台灣」